MedTrace Logo

Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis

NCT02038985 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-10-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of fluorescence imaging + Indocyanine Green (ICG) dye ("Firefly"), compared to standard white light imaging in 2D and 3D, for accurate visual diagnosis of endometriosis during a da Vinci robotically guided endometriosis resection procedure.

Conditions

  • Endometriosis

Interventions

OTHER

Participants will receive ICG Dye

Participants will receive ICG Dye preoperatively for use in the Visual Diagnosis of Endometriosis

Sponsors & Collaborators

  • AdventHealth

    lead OTHER

Principal Investigators

  • Aileen Caceres, MD · Florida Hospital Celebration Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-07-31
Completion
2016-08-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02038985 on ClinicalTrials.gov